You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地藥監部門嚴厲打擊製售假劣新冠藥品違法犯罪行為
國家藥監局公布,部署各地藥品監管部門持續加強對疫情防控相關藥械的質量監管,加大對製售涉疫藥械違法犯罪行為的打擊力度。 其中,針對近期市場上出現的非法銷售來源不明的新冠病毒感染治療藥品線索,多地藥品監管部門採取線上監測和線下摸排相結合的方式,嚴查違法。在統一指揮下,地方藥品監管部門會同屬地公安部門聯合執法,已搗毀部分犯罪團夥及窩點,並在收網行動中現場查獲一批假冒Paxlovid (奈瑪特韋片/利托那韋片組合包裝)及未經批准進口藥品等。經檢驗,查獲的部分產品不含有效藥品成分或非法添加其他藥品成分,涉嫌違反內地銷售假藥罪的規定。目前,案件正在由公安部門依法辦理中。 國家藥監局組織全國藥品監管部門進一步加大對製售假劣新冠病毒感染治療藥品的監測、摸排、檢查和案件查辦力度,發現涉嫌犯罪的,依法移送公安司法機關。同時,當局正依法依規推動新冠病毒治療藥物研發上市,服務疫情防控大局。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account